EGFR and head and neck squamous cell carcinoma: For the last few years, studies have shown that modulators of redox metabolism were promising strategies for clinical management of HNSCC, including detection and diagnosis, synergizing the efficacy of conventional radiotherapy, chemotherapy, EGFR targeted therapy, and immunotherapy32,33.